AstraZeneca PLC (AZN)
After hours:
| Previous close | 68.34 |
| Open | 68.18 |
| Bid | 68.25 x 800 |
| Ask | 68.42 x 1100 |
| Day's range | 68.04 - 68.72 |
| 52-week range | 52.65 - 71.70 |
| Volume | |
| Avg. volume | 6,184,724 |
| Market cap | 213.837B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 106.98 |
| EPS (TTM) | 0.64 |
| Earnings date | N/A |
| Forward dividend & yield | 1.45 (2.19%) |
| Ex-dividend date | 11 Aug 2022 |
| 1y target est | 71.90 |
- Zacks
Pharma Stock Roundup: PFE & AZN Ink New M&A Deals, LLY Meets Alzheimer's Study Goal
Pfizer (PFE) and Roivant Sciences (ROIV) form a new Roivant subsidiary to develop an inflammatory disease drug. AstraZeneca (AZN) to boost cell therapies portfolio with private company buyout.
- Motley Fool
2 Stocks That Could Surprise Investors in 2023
The healthcare industry can make for a safe place to invest regardless of the macroeconomic conditions. A couple of healthcare stocks that are diversified and that could be good buys heading into the new year are AstraZeneca (NASDAQ: AZN) and PetMed Express (NASDAQ: PETS). AstraZeneca's business performed well in 2022, but its stock isn't doing as well as perhaps it should be.
- Motley Fool
Why Shares of Compugen Rose 16.5% on Wednesday
Shares of Compugen (NASDAQ: CGEN), a clinical-stage biotech company that specializes in immunology therapies to treat cancer, saw its shares rise 16.5% on Wednesday. The stock closed on Tuesday at $1.03, then opened on Wednesday at $1.01, before jumping to $1.23 in the late afternoon and closing at $1.20. The stock has been volatile, with a 52-week low of $0.51 and a 52-week high of $4.88.
